In-line measurement and / or detection of analytes, contaminants and physical properties in body fluid management systems
The body fluid management system addresses the limitations of current systems by integrating wearable sensors and machine learning for real-time, accurate, and automated fluid analysis and diagnostics, enhancing patient safety and clinical efficiency.
Patent Information
- Application Number
- JP2024526655
- Authority / Receiving Office
- JP · JP
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2022-03-02
- Filing Date
- 2022-11-03
- Publication Date
- 2024-11-08
AI Technical Summary
Current body fluid management systems are cumbersome, prone to errors, and pose risks due to manual recalibration, inter-rater variability, and slow analysis methods, lacking real-time, accurate, and automated solutions for pressure monitoring and fluid analysis.
A body fluid management system with integrated sensing assemblies for real-time detection of analytes and physiological parameters, including customizable sensor assemblies that communicate with a control system for automated diagnostics and fluid management, utilizing wearable sensors and machine learning for continuous monitoring and analysis.
Enables rigorous, accurate, and automated fluid management with real-time qualitative or quantitative insights, reducing errors and risks, and facilitating rapid diagnostic decisions.
Smart Images

Figure 2024541279000001_ABST
Abstract
Description
[Technical field]
[0001] FIELD OF THE DISCLOSURE The present disclosure relates generally to fluid management systems and related methods. [Background technology]
[0002] 2. Description of Related Art Gravity-based fluid drainage has been practiced for centuries, beginning with unrestricted drains intended to completely drain fluid from a body compartment, such as urinary catheters. Controlled partial drainage of cerebrospinal fluid to relieve pressure on the brain has been used for approximately 300 years, and the technique was further advanced in 1927 with the addition of fluid pressure measurement with a manometer. Manometers measure pressure using the difference in height of a column of fluid and must be aligned to an anatomical marker. Despite these advances, common practice today involves a combination of various devices such as manometer-based drains, external pressure transducer assemblies, arterial blood pressure modules attached to bedside patient monitors, and other equipment that requires complex and frequent management by clinical users, either by manually switching devices or extracting samples, resetting the system every time the patient moves, or frequent recalibration due to pressure sensor inaccuracies.
[0003] Current methods of analyzing body fluids are slow and / or subjective, and pose unnecessary risks to patients. Physical analysis of body fluids is often performed as a visual assessment at the bedside, but there is a large degree of variability between assessors. Conclusions can vary widely depending on the observer's attention, training, and acuity, as well as the conditions under which the observation is made (e.g., lighting, background, ambient temperature). Chemical analysis of body fluids is typically performed by taking a sample from the patient and sending the sample to a laboratory. The current process is cumbersome, prone to error (e.g., sample mix-up, contamination), and dangerously slow for critically ill patients. Summary of the Invention [Means for solving the problem]
[0004] Disclosed herein are fluid management systems and related methods that, in addition to performing pressure monitoring and fluid drainage, also include sensing assemblies capable of in-line detection of analytes and physiological parameters of a subject fluid, and sensing bodily motion, which may include the presence and / or concentration of bacteria, viruses, proteins, chemicals, elements, hormones, or other biomarkers or contaminants in the subject fluid, physiological parameters such as fluid opacity, particle count, and temperature, or position and movement of the head, torso, legs, feet, etc., to determine body position, gait, and movement intervals.
[0005] These sensing capabilities can provide real-time qualitative or quantitative insights from the bedside and can be used in combination or individually to support more rigorous, accurate, and automated local and remote collaboration than is currently available in clinical practice. In certain embodiments, these sensing assemblies introduce fluid analysis without disrupting closed systems for sample collection. Wearable sensing assemblies also enable continuous sensing and trending of parameters for which only intermittent sample analysis exists in the art. In certain combinations, they represent novel diagnostic medical systems that can characterize cerebrospinal fluid (CSF) volume and flow within the central nervous system and automate management of diagnostic procedures for conditions such as normal pressure hydrocephalus, cerebrospinal fluid leaks, and related conditions of abnormal CSF circulation or volume.
[0006] Additionally, while many attempts are underway to improve specific analytical capabilities, there remains a need in the art for a clinical deployment platform to expedite the progression of novel sensing to commercialization.The disclosed system introduces a platform with a common fluid management system with customizable and interchangeable sensor assemblies that can communicate individual results individually or in combination to derive a diagnostic outcome.
[0007] The bodily fluid management system can be summarized as including a control system assembly for real-time monitoring of a pressure of the bodily fluid, a patient interface assembly including at least one wearable pressure sensor assembly, and at least one sensor assembly configured to detect at least one parameter of the bodily fluid. The control system assembly can include integrated control of drainage of the bodily fluid. The wearable pressure sensor assembly can be configured for attachment to a patient near an anatomical marker. The wearable pressure sensor assembly can include at least one pressure sensor in direct fluid communication with the bodily fluid. The control system can be configured to monitor changes in pressure of the bodily fluid. The at least one sensor assembly can be an analyte sensor assembly in direct fluid communication with the bodily fluid. The control system assembly can include integrated control of drainage of the bodily fluid. The analyte sensor can be disposed within a sealed fluid path of the bodily fluid. The analyte sensor assembly can be configured to detect a salinity concentration of the bodily fluid. The analyte sensor assembly can be configured to detect a glucose concentration of the bodily fluid. The analyte sensor assembly can be configured to detect a protein concentration of the bodily fluid. At least one sensor assembly may be a physiological sensor assembly. The physiological sensor assembly may be configured to detect a color of the bodily fluid. The physiological sensor assembly may be configured to detect an opacity of the bodily fluid. The physiological sensor assembly may be configured to detect particles in the bodily fluid. The physiological sensor assembly may be configured to detect an oxygen concentration of the bodily fluid. The control system may communicate quantitative values obtained from the sensor assembly. The control system may communicate qualitative parameters from the sensor assembly.
[0008] The fluid management system can be summarized as including a control system assembly for real-time monitoring of fluid pressure and integrated control of fluid drainage, a patient interface assembly including at least one wearable pressure sensor assembly, and at least one customizable sensor assembly configured to integrate a replaceable sensor subassembly. The replaceable sensor subassembly can be a replaceable analyte detection subassembly. The replaceable sensor subassembly can include a printed circuit board. The replaceable sensor subassembly can be in communication with the control system assembly.
[0009] The fluid management system can be summarized as including a control system assembly for real-time monitoring of pressure of the fluid and integrated control of drainage of the fluid, a patient interface assembly including at least one wearable pressure sensor assembly, and at least one wearable motion sensor assembly. The patient interface assembly can include at least one directional sensor configured to detect an orientation of a body cavity containing the fluid and a movement of the body cavity. The wearable motion sensor assembly can include at least one motion sensor configured to detect body movement. The at least one wearable motion sensor assembly can include two wearable motion sensor assemblies configured to be worn, one on each ankle. The at least one wearable motion sensor assembly can include two wearable motion sensor assemblies configured to be worn, one on each shoe. The at least one wearable motion sensor assembly can be configured to be worn in the lumbar region. The control system assembly can be configured to derive gait from an input of the patient interface assembly. The control system assembly can be configured to detect normal pressure hydrocephalus that can be ameliorated by a shunt. [Brief description of the drawings]
[0010] [Figure 1A]1 shows a fluid management system. [Figure 1B] 1 illustrates an alternative fluid management system. [Figure 1C] 1 illustrates an alternative fluid management system. [Figure 1D] 1 illustrates an alternative fluid management system. [Diagram 2] 1 illustrates a patient interface assembly of a fluid management system. [Diagram 3] FIG. 1 illustrates a top view of a wearable sensor assembly of a patient interface assembly of a fluid management system. [Figure 4] FIG. 4 illustrates a side cutaway view of the wearable sensor assembly of FIG. 3. [Figure 5A] 1 shows the fluid lines of a fluid management system. [Figure 5B] 1 illustrates fluid lines of an alternative fluid management system. [Figure 5C] 1 illustrates fluid lines of an alternative fluid management system. [Figure 6] 1 illustrates a fluid management system having multiple bodily fluids. [Figure 7] 1 illustrates a simplified operational diagram of a fluid management system that uses multiple fluids and associated derived parameters to control drainage. [Figure 8] 1 illustrates a control system assembly for a fluid management system. [Figure 9] 9 illustrates another view of the control system assembly of FIG. 8. [Figure 10] 1 illustrates a fluid management system with a replaceable sensor assembly. [Figure 11] 1 illustrates another fluid management system with a replaceable sensor assembly. [Figure 12A] 1 illustrates an alternative fluid management system. [Figure 12B] 1 shows a fluid management system with an assay interface assembly. [Figure 13] 1 shows the assay interface assembly. [Figure 14] 1 shows a simplified operational diagram of a fluid management system that uses a sensing assembly and associated derived parameters to control drainage. [Figure 15] 1 illustrates a fluid management system with a wearable motion sensor assembly. [Figure 16] 1 illustrates a fluid management system with multiple access points for the same type of fluid. [Figure 17A] 1 illustrates a first schematic of a wearable sensor assembly of a patient interface assembly of a fluid management system. [Figure 17B] 17B shows a second schematic of the wearable sensor assembly of FIG. 17A. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0011] The disclosed system improves upon existing technology by facilitating consistent and rapid detection of target analyte(s) and / or contaminant(s) via continuous pressure monitoring, controlled fluid drainage, physiological sensing, motion sensing, and a fluid management and diagnostic platform that may include customizable sensor assemblies with a common control and communication interface.
[0012] A bodily fluid management system and associated methods are disclosed that incorporate in-line detection of analytes and / or contaminants in a subject bodily fluid.
[0013] Bodily fluids in this context may include cerebrospinal fluid (CSF), blood, urine, wound exudates, interstitial fluid, etc. Analytes in this context may include bacteria (or bacterial by-products), viruses, cells (such as cancer cells, inflammatory cells, leukocytes, white blood cells, or red blood cells), proteins (such as albumin, tau, hemoglobin, immunoglobin, or other proteins associated with the presence of cancer cells, infections, or congenital diseases), amyloid beta peptides, prions, compounds or molecules, chemical elements (such as heavy metals), hormones, biomarkers, glucose, lactate, pyruvate, gamma aminobutyric acid (GABA), glutamate, sodium, potassium, creatine kinase, neurotransmitters, other bodily fluids (such as blood in CSF or urine), exogenous compounds (such as pharmaceuticals), etc.
[0014] The disclosed system can utilize existing analyte sensors known to be clinically important in new ways (such as electrochemical glucose sensors, conductivity or salt sensors, urinary calcium sensors, chloride sensors, etc.) The disclosed system can integrate new modalities such as lab-on-a-chip based sensing of unprocessed whole blood or interstitial fluid.
[0015] Additionally, the disclosed system can enable clinical evaluation of novel third party sensors via the disclosed sensing platform that includes customizable sensor assemblies configured in operative communication with a common control system assembly.
[0016] Physiological parameters in this context may include color, opacity, turbidity, volume, flow rate, particle count, and temperature. Fluid pressure is a physiological parameter, but is referred to separately in the context of this disclosure. Pulse pressure variations, cerebral compliance, and other information obtained from pressure waveforms or changes related to drainage may be considered physiological.
[0017] A wearable motion sensing assembly, also known in this context as a patient motion tracking assembly, motion tracking assembly, motion sensor assembly, kinesthetic sensing assembly, etc., is a wearable assembly that measures the orientation, position, and / or movement of a body, body cavity, body compartment, limb, or other anatomical feature, intended for use in conjunction with a fluid management system to provide an additional source of data for more complex analysis. These assemblies may include one or more directional sensors, motion sensors, accelerometers, gyroscopes, contact force sensors, etc. When used in this context, the words "motion" or "movement" may refer to the lack of motion, or to the orientation or position of the body or body parts.
[0018] The control system assembly may communicate with the sensor assembly via a common electrical interface(s) to obtain data from the sensor(s) and present relevant information and / or recommendations to a user or a third party physical or virtual display or data repository (such as an EMR or database).
[0019] The customizable sensor assembly can be configured to accept a variety of sensing elements to detect the presence and / or concentration of various analytes or contaminants in bodily fluids. In-line analyte sensor data can also be combined with physiological sensor data such as temperature, gyroscope, optical / visual, motion data including the use of multi-axis accelerometers, and patient physical attributes (e.g., height, weight, mobility, etc.) to perform more complex considerations.
[0020] The control system assembly can use machine learning (ML) algorithm(s), and / or image processing, and / or computer vision, and / or input(s) from other source(s), such as user input, input from various sensing modalities (light sensors, flow sensors, drip sensors, color sensors, cameras, temperature sensors, etc.) contained within the control system assembly, in combination with data from sensors contained within the customizable sensor assembly to generate relevant information and / or recommendations for the user.
[0021] The sensors in the sensor assembly may include a variety of technologies and sensing modalities, such as chemical, electrochemical, optical, etc. Certain embodiments of the disclosed system may include "active" sensors that generate an electrical signal (such as voltage, resistive, capacitive, digital, etc.) or an optical signal (such as fluorescent, infrared, etc.) that can be read by the control system assembly. Other embodiments may include "passive" indicator(s), such as a material that changes color in the presence of a particular analyte, chemical, etc. Such materials may be affixed to or embedded in a suitable substrate (such as paper, tubing, fabric, plastic, silicon, metal, etc.) by printing, gluing, impregnation, co-extrusion, deposition, etc., depending on the particular material / substrate combination. In the case of passive indicators, the disclosed system may include a secondary sensor and circuitry to detect the output of the indicator (such as a color change), or a camera to visually assess the change, or the indicator may simply be in a location that is visually observable by a user.
[0022] In certain embodiments, the disclosed system can provide multimodal monitoring of analytes and / or derived parameters such as lactate pyruvate ratio, blood or tissue oxygenation. Also, concentrations of analytes between two bodily fluids can be compared to characterize their distribution in the body. For example, the presence of an exogenous compound in blood versus CSF to characterize blood-brain barrier permeability, which is particularly relevant for pharmaceutical research, or blood glucose / brain glucose ratios to determine patient-specific brain glucose concentrations or albumin indices by comparing blood and CSF albumin levels to assess blood-brain barrier disruption. These sensors may be continuous and present trends or averages, or they may be intermittent or single time points. These values may be communicated directly to a user, used by the disclosed system as part of an alarm condition, or integrated with other inputs for screening, diagnosis, or prognosis. For example, abnormally low CSF glucose concentrations relative to a patient's blood glucose levels are clinically significant and often associated with conditions such as infection. Thus, low CSF glucose values may be communicated to a third party monitor or database via a graphical user interface or with or without an alarm. In other embodiments, the disclosed system can evaluate measurements against set thresholds or trend curves to determine and communicate "suspected bacterial meningitis."
[0023] In other embodiments, the disclosed system can provide diagnostic detection of the presence of antibodies, proteins, or similar biomarkers associated with diseases such as hospital acquired infections (C-diff, MRSA, etc.), leptomeningeal or other cancers, Alzheimer's, Parkinson's, or other neurodegenerative diseases, or one or more of over 700 rare brain diseases. The disclosed system sensing assembly can also be combined with other data sources to provide prognosis for these and other diseases such as limb-onset ALS, where higher protein levels in the CSF are thought to indicate blood-brain barrier disruption and are associated with increased mortality.
[0024] Certain embodiments of the disclosed system may include a patient interface assembly and a control system assembly. In embodiments of the disclosed system, the patient interface assembly is disposable (single patient use) and the control system assembly is durable (multiple patient use). The sensors may be located within the patient interface assembly, the control system assembly, or may be provided as a separate assembly that is durable or disposable depending on the particular sensor type and configuration.
[0025] In other embodiments, the system is completely disposable and can communicate monitoring data and alarms to a third party graphical user interface or database via a wired or wireless connection.
[0026] In certain embodiments, the disclosed systems can be configured to provide therapeutic drainage (i.e., removal of bodily fluids from the body). In such embodiments, the control system assembly can include, in operable communication, a user interface, a primary flow control actuator, a secondary flow shutoff actuator, and a bodily fluid flow sensor (e.g., a drip detector, a mass flow sensor, etc.).
[0027] In other embodiments, the disclosed system may be configured to manage multiple bodily fluids. These may be multiple bodily fluids of a single patient, or may include managing a single bodily fluid of multiple patients simultaneously. In such embodiments, the patient interface assembly may accommodate multiple patient tubing lines, or the control system assembly may accommodate multiple patient interface assemblies. In such embodiments, one or more bodily fluids may be in fluid communication with the sensor for monitoring purposes, and one or more fluids may be monitored and discharged for therapeutic purposes. Sensing of an analyte of the fluid or a physiological property of the fluid may occur in one or more of the fluids.
[0028] In other embodiments, the disclosed systems may be configured to recirculate bodily fluids back into the body. In such embodiments, the control system assembly may further include a pumping mechanism, heating and / or cooling elements, filtration element(s), and / or additional sensor(s), and the patient interface assembly may include additional fluid line(s) for connecting the patient at one or more access location(s).
[0029] 1A-1D are line diagrams showing simplified views of possible configurations of the disclosed system in relation to a patient's anatomy, where the system is configured for monitoring and / or therapeutic drainage of bodily fluids and in-line detection of analytes in bodily fluids, with the sensor assembly integrated within the patient interface assembly. FIG. 1A shows an embodiment of the disclosed system configured to connect to a ventricular catheter for monitoring, drainage, and analysis of CSF. FIG. 1B shows an embodiment of the system configured to connect to a lumbar catheter for monitoring, drainage, and analysis of CSF. FIG. 1C shows an embodiment of the system configured to connect to a urinary catheter for monitoring, drainage, and analysis of urine. FIG. 1D shows an embodiment of the system configured to connect to an invasive blood pressure catheter for monitoring and analysis of blood.
[0030] 1A, the disclosed system includes a control system assembly 200 and a patient interface assembly 100. The patient interface assembly 100 may include a cartridge subassembly 101 for interfacing with the control system assembly 200, a non-compliant fluid drainage tube 103 and a fluid collection reservoir 102 for therapeutic drainage and collection of CSF, a wearable pressure sensor assembly 104 configured for attachment to a patient near a suitable anatomical marker 105 such as the external auditory canal (EAM), and a fluid-tight connector 106 (e.g., luer fitting, neuro fitting, etc.) for connecting to an implantable ventricular catheter 107a.
[0031] In a related embodiment, the patient interface assembly may be connected to a catheter implanted in the lumbar region of the spine (e.g., lumbar catheter 107b shown in FIG. 1B). In a related embodiment, the patient interface assembly may include a wearable sensor assembly attached to an anatomical marker appropriate for the pressure of the fluid to be measured. If the bodily fluid is blood, the intersection of the fourth intercostal space and the mid-axillary line may serve as an anatomical marker for the heart. In other embodiments, the wearable pressure sensor assembly 104 may include a direction sensor, a motion sensor, a patient motion tracking assembly, a contact force sensor, or other sensing assembly.
[0032] As shown in Figures 1C and 1D, some embodiments may be configured to use an exogenous fluid 121 (saline, liquid medication, etc.) delivered via an infusion line 108 to a bidirectional non-compliant bodily fluid line 109, which may be connected to a urinary catheter (e.g., a Foley catheter) 107c as shown in Figure 1C, an arterial catheter 107d as shown in Figure 1D, a venous catheter, or other similar device appropriate for the subject's bodily fluid. Further embodiments may include the use of a peristaltic pump 122 and / or a Y-fitting inside the cartridge 101 to control the infusion of the exogenous fluid 121. In embodiments where the system is not configured for therapeutic drainage, such as that shown in Figure 1D, a bodily fluid communication sensor assembly may be located in the wearable pressure sensor assembly 104 or along the bidirectional line 109.
[0033] Figure 2 is a diagram showing a perspective view of the patient interface assembly 100. As shown in Figure 2, the patient interface assembly 100 can include a flow measurement interface 123 (such as a drip chamber, cuvette, tubing, etc.) for interfacing with a bodily fluid flow sensor 228 of the control assembly 200, a flow control actuator interface 125 (such as soft flexible tubing such as silicone, polyurethane, polypropylene based elastomer, etc.) for interfacing with a primary flow control actuator 222 within the control system assembly 200, and a flow shutoff actuator interface 126 (such as a spring loaded button, stopcock, pinch valve, etc.) for interfacing with a secondary flow shutoff actuator 230 of the control assembly 200. The patient interface assembly 100 includes a drain tube 103 (silicone, polyurethane, polypropylene-based elastomer, etc.) configured with a fitting 106 (luer fitting, neuro fitting, or other removable fitting) at its inlet end for interfacing with an implanted catheter and a fitting 144 at its outlet end for interfacing with a removable fluid collection reservoir 102 (a bag made of polyethylene, PVC, etc.) for collecting the fluid. The flow measurement interface 123 can include an orifice that produces droplets of known size for counting the number of droplets detected by the fluid flow sensor 228 of the control system assembly 200 and accurately calculating the flow rate based on multiplying the number of droplets by a known droplet size.
[0034] The patient interface assembly 100 may also include an electrical cable 116 between the wearable pressure sensor assembly 104 and the cartridge subassembly 101, and a set of exposed conductive pads 124 (gold, copper, carbon, silver ink, etc.) on the cartridge subassembly 101 for passing electrical signals, data, power, etc. between the patient interface assembly 100 and the control system assembly 200. In such an embodiment, a set of corresponding spring contacts (pogo pins, battery-powered contacts, etc.) on the control system assembly 200 may interface with the conductive pads on the patient interface assembly. Other embodiments of the cartridge subassembly 101 may alternatively include a conventional electrical connector that is manually inserted by a user into a corresponding receptacle on the control system assembly 200. In still other embodiments, the physical electrical interface may be replaced entirely by implementing wireless communication (Bluetooth, Wi-Fi, etc.) between the patient interface assembly 100 and the control system assembly 200, or between the patient interface assembly 100 and a remote control system (a cloud-based system, an on-site or off-site server, a smartphone or tablet-based application, etc.). In such a configuration, the wearable pressure sensor assembly 104 can be powered by a battery or similar power source.
[0035] In certain embodiments, the cartridge subassembly 101 may include a peristaltic pump or similar mechanism, or may interface with such a mechanism of the control system assembly 200. In other embodiments, the cartridge subassembly 101 may include additional fluid line(s) for connection to an infusion source and / or secondary or tertiary patient fluid catheters. In yet other embodiments, the patient interface assembly 100 may comprise a simple volume-limited reservoir incorporating one or more of the sensors described herein.
[0036] Patient interface assembly 100 may include one or more sensor assemblies, including a customizable sensor assembly, or the sensor assembly may be a separate assembly from patient interface assembly 100.
[0037] Figures 3 and 4 are diagrams illustrating top and side cutaway views, respectively, of an embodiment of a wearable pressure sensor assembly 104. Figure 3 illustrates the integration of a fluid communication sensor in the wearable pressure sensor assembly 104, and Figure 4 illustrates the integration of a physiological non-fluid communication sensor in the wearable pressure sensor assembly 104.
[0038] As shown in FIG. 3, the wearable pressure sensor assembly 104 may include a flow path 110 with a fluid inlet 111a and a fluid outlet 111b opposite the fluid inlet 111a, pressure sensors 119a and 119b in fluid communication with the bodily fluid to measure the pressure of the bodily fluid, and a directional sensor 115 (such as an accelerometer) for detecting patient movement. The wearable pressure sensor assembly 104 may further include a housing 117 with suture points 118 for attaching the wearable pressure sensor assembly 104 to the patient (as shown in FIG. 1). The wearable sensor pressure assembly 104 may include one or more fluid communication sensors 132 for detecting physiological parameters such as analytes or temperature. The fluid communication sensors may be electrical, such as measuring salinity, or electrochemical, such as detecting glucose, or bioelectrical, such as molecularly imprinted polymer membranes or other forms of analyte sensors or biosensors known in the art.
[0039] As shown in FIG. 4, certain embodiments of the wearable pressure sensor assembly 104 may further include a physiological sensor assembly including an illumination source 120 (such as an LED) and a light sensor 114 (such as a color sensor AMS TCS34725 or similar, a camera, etc.) for detecting changes in one or more physical attributes (such as color, turbidity, etc.) of the subject's bodily fluid. The light sensor 114 and illumination source 120 may be oriented toward the flow path 110, which may include a transparent or translucent side 112a facing the light sensor 114 and illumination source 120, and an opposing side 112b providing a reflective or color reference surface (e.g., white). In other embodiments, the illumination source 120 and the light sensor 114 may be configured on opposite sides of the flow path 110. In related embodiments, the light sensor 114 may include an array of multiple light sensors, and the illumination source 120 may include an array of multiple illumination sources. The illumination source(s) can be configured to illuminate the fluid in the flow path with a particular wavelength, spectrum, or intensity of light that aids in the detection of a particular contaminant(s) by the optical sensor(s) (e.g., a red or yellow shade indicating traces of blood or pus in normally clear CSF, a dark yellow or brown shade indicating substandard kidney function in otherwise light yellow urine, etc.). The illumination source(s) can further be configured to switch, sequentially or as desired by the control system assembly, between different wavelengths, spectra, or intensities optimized to enhance detection of a particular contaminant.
[0040] As shown in FIGS. 3 and 4, the sensing assembly including associated components (e.g., light sensor 114, illumination source 120, direction sensor 115, pressure sensors 119a and 119b, fluid communication sensor 132, etc.) may be co-located on a printed circuit board ("PCB") 113 (including substrates such as FR4, Kapton, polyester, etc.) and utilize a single communication and power interface along electrical cable 116. In related embodiments, wireless technology may be used to achieve power transmission (e.g., inductive or resonant inductive coupling) and / or signal communication (e.g., RF, infrared, etc.). In other related embodiments, the wearable pressure sensor assembly 104 may be internally powered (e.g., battery, capacitor, etc.). In further embodiments, multiple wearable sensor assemblies may be positioned at any suitable location along the fluid drainage line 103 or bidirectional line 109.
[0041] In other embodiments, as shown in Figures 5A-5C, a fluid communication sensor(s) optimized for detecting one or more of the analytes or contaminants described elsewhere herein may be placed directly on and / or in any suitable location in a fluid line 127, such as the bodily fluid drainage line 103 or bidirectional line 109. Figure 5A illustrates the use of a sensing band 128, such as a colorimetric coated sensor, that delivers a visually detectable result directly to the user. Figure 5B illustrates the use of a continuous sensing strip 129, which may include a colorimetric coating as described herein, or may include a flex circuit adhered to the inner surface of the fluid line 127 or suspended within the bodily fluid of the fluid line 127.
[0042] In other embodiments, the fabric of the fluid line 127 itself may include a sensing material, such as a leuco dye, which may function as a colorimetric sensor due to its chemical form change properties triggered by heat, light, or changes in pH. In a related embodiment, as shown in FIG. 5C, the electronic fluid communication sensor 130 may be embedded in the fluid line itself using overmolding, co-extrusion, or other manufacturing methods and an electrical cable 131 or flat flex circuit that may be fabricated inside the tubing and / or attached to the inside or outside of the fluid line 127.
[0043] In other embodiments, the sensor and / or illumination source may be located in any other suitable location along the fluid line (e.g., in a second sensor assembly, in the cartridge, between the cartridge and the drainage reservoir, etc.). In still other embodiments, the sensor and / or its illumination source(s) that do not directly contact the fluid in the drainage line may be located within the control system assembly or may be provided as a separate assembly that can be used in operative communication with the control system assembly 200. In related embodiments, the sensor(s) and / or illumination source(s) may be partially or completely housed in an opaque or semi-opaque housing(s) to minimize and / or control interference from ambient light.
[0044] Figure 6 is a diagram illustrating an embodiment of the presently disclosed fluid management system in which one or more patient interface assemblies are in fluid communication with multiple bodily fluids. As shown in Figure 6, the patient interface assembly 100 may include a cartridge subassembly 101 for interfacing with a control system assembly 200, a non-compliant fluid drainage tube 103 for connection to a proximal end of an implanted ventricular catheter 107a and a removable fluid collection reservoir 102 at a distal end for therapeutic drainage and collection, a wearable pressure sensor assembly 104a configured for attachment to a patient near a suitable anatomical marker such as the external auditory canal (EAM), and a fluid-tight connector 106 (luer fitting, neuro fitting, stopcock, etc.) for connection to the implanted ventricular catheter 107a. The patient interface assembly 100 may further comprise a secondary fluid line 145 that may allow for the use of exogenous fluid 121 (saline, liquid medication, etc.) delivered via the infusion line 108 to the bidirectional non-compliant bodily fluid line 109 and may be connected at its proximal end to an arterial catheter 107d or other similar device suitable for the subject's bodily fluids, such as a venous catheter, a urinary catheter, etc. Further embodiments may include the use of a peristaltic pump 122 and / or a Y-fitting inside the cartridge 101 to control the infusion of the exogenous fluid 121. In embodiments where the secondary fluid line 145 is not configured for therapeutic drainage, a bodily fluid communicating sensor assembly, such as an analyte assembly, may be placed in the wearable pressure sensor assembly 104 or along the bidirectional line 109 to a connector to the arterial catheter 107d.
[0045] In other aspects, the patient interface assembly may further include a first wearable pressure sensor assembly 104a attached to the patient substantially near an anatomical marker suitable for monitoring ICP (EAM), and a second wearable pressure sensor assembly 104b attached to the patient substantially near an anatomical marker suitable for monitoring blood pressure (such as the mid-axillary line at the left fourth intercostal space).
[0046] Each of the first and second wearable pressure sensor assemblies may include an orientation sensor to monitor patient movement and posture and check for errors in pressure sensor readings, as described elsewhere herein. Incorporating multiple motion sensors or wearable motion sensing assemblies may facilitate more detailed tracking of patient posture (e.g., tracking the patient's torso orientation independent of head orientation, more accurately modeling the spinal column and associated CSF pressure in 3D space in real time). Such information may be utilized by the system control assembly to automatically adjust displayed values to more accurately reflect the actual values of certain parameters at anatomical points of interest, or to track patient motion over time (e.g., to ensure the patient is being moved often enough to prevent pressure injury, or to monitor a patient who may be waking up from a coma or sedated state). Additional physiological and analyte sensing assemblies may be located within or along the wearable pressure sensor assemblies 104a and 104b, the drainage lines 103 or 109, in the cartridge 101, or within the console 200.
[0047] In certain embodiments, the first wearable pressure sensor assembly 104a may monitor only ICP, while the second wearable pressure sensor assembly 104b may monitor both ICP and blood pressure. Such an arrangement provides a pressure reference for ICP that is normalized at the same height as the blood pressure reference to accurately calculate cerebral perfusion pressure. In another embodiment, the second wearable pressure sensor assembly 104b may monitor only blood pressure. In certain embodiments, the disclosed system may use data from the wearable pressure sensor assembly 104a in combination with data from the wearable pressure sensor assembly 104b and other sensing assemblies to calculate derived parameters. For example, the disclosed system may calculate real-time perfusion pressure, which is the net pressure gradient that determines blood circulation through a particular body compartment or cavity. This can be calculated utilizing the mean arterial pressure measured by a wearable pressure sensor assembly 104b attached to the patient substantially near an anatomical marker suitable for monitoring blood pressure and subtracting the fluid pressure of the body cavity for which perfusion pressure is desired, also measured by 104b at the same blood pressure anatomical marker. Examples include cerebral perfusion pressure, where the body cavity is the cranial compartment, spinal cord perfusion pressure or lumbar perfusion pressure, where the body cavity is the spinal column, specifically the intrathecal cavity surrounding the spinal cord, and abdominal perfusion pressure, where the body cavity is the abdominal cavity.
[0048] In further embodiments, the pressure or flow rate of a single fluid may be monitored and / or controlled to achieve a target perfusion pressure rather than a target fluid pressure. The logic of one such embodiment is shown in FIG. 7. A system that automatically manages fluid pressure and drainage flow rate based on derived parameters (such as CPP) represents a significant advance over the prior art and enables exciting and useful clinical applications that are not possible or practical with existing technology. Similarly, in certain embodiments, the flow rate of bodily fluids may be controlled to achieve a target sensed parameter, as described below.
[0049] In certain embodiments, the system may include a peristaltic or similar pumping mechanism for controlling other fluids known in the art (such as saline, artificial CSF, etc.) for purposes such as periodic flushing, back pressure (such as in the case of an arterial line), etc.
[0050] In certain embodiments, the patient interface assembly 100 may include multiple fluid lines as shown in FIG. 6, or the control system assembly 200 may interface with multiple patient interface assemblies. These interfaces may be physical interactions, such as the insertion of a cartridge 101, or may be digital interactions, such as wireless communication from a sensing assembly to a control assembly, an external display, or a database. In these multiple fluid embodiments, one or more bodily fluids may be in fluid communication with a sensor for monitoring purposes, but in addition to monitoring and sensing, one or more fluids may be drained for therapy. In other embodiments, the system may be configured to independently monitor or control two bodily fluids.
[0051] Sensing of a fluid analyte or a physiological property of a fluid may occur in one or more fluids. Each parameter may be measured and reported separately. The disclosed system may include calculation of derived parameters or compare concentrations of analytes between two fluids to characterize their distribution in the body. Examples include detecting the presence of an exogenous compound in blood versus its presence in CSF to characterize the permeability of the blood-brain barrier, or detecting blood glucose and brain glucose concentrations to calculate a blood / brain glucose ratio to determine whether a patient-specific brain glucose concentration is within an expected range.
[0052] In some embodiments including multiple fluid lines, the patient interface assembly 100 may be comprised of a single integrated assembly, while in other embodiments the primary, secondary, and tertiary lines and their associated components may be separate patient interface assemblies. In some embodiments, various aspects of the pump mechanism 122 may be split between the patient interface assembly 100 and the control system assembly 200.
[0053] 8 and 9 are diagrams illustrating perspective views of an embodiment of a control system assembly 200 configured for use in operative combination with a patient interface assembly.
[0054] 8, the control system assembly 200 may include a cartridge recess 232, a fluid tube inlet recess 234, a fluid tube outlet recess 226, and a cartridge latch mechanism 201 for holding the cartridge subassembly 101 in alignment within the control system assembly 200 during operation of the system. In certain embodiments, the cartridge recess 232 may further include finger / hand clearance feature(s) 224 to facilitate insertion and removal of the cartridge subassembly 101 by a user.
[0055] The control system assembly 200 may further include a user interface 242 for receiving user input (settings, patient information, etc.) and displaying system settings and outputs (set points, alarm thresholds, current or historical pressure or flow data, alarms, notifications, waveforms, patient information, etc.). In certain embodiments, the user interface 242 may include a graphical display (LCD, OLED, etc.), a touch screen (resistive, capacitive, projected capacitive, etc.), a button keypad (plastic or elastomeric buttons, membrane switches, etc.), an LED array (7-segment, individual indicators, etc.), or any similar element suitable for entry of user input and display of system settings and outputs. In other embodiments, this user interface for receiving user input and displaying system settings and outputs may be located in a web browser, smartphone, external monitor, or other third party device in communication with the control system assembly.
[0056] The control system assembly 200 may further include an adjustable clamping mechanism 214 for securing to an IV pole 211, bed rail, or other similar patient room furniture. In other embodiments, the control system assembly 200 may be configured to be cart mounted, wall mounted, freestanding, or otherwise secured within a transport vehicle, including at angles that are not parallel to the ground to compensate for vehicle movement. In other embodiments, the control system assembly may be configured to be carried on a handle or placed on the patient's bed or transfer device during transport.
[0057] As shown in FIG. 9, the control system assembly 200 may include a receptacle 212 for connection to an external power source (such as an AC mains power source, a DC network, etc.) and may optionally include an internal power source (such as a rechargeable battery).
[0058] In a further aspect, the control system assembly 200 may include an electrical interface 202 (such as a connector / socket, a pogo pin array, a spring-loaded contact array, etc.) for DC power distribution and electrical signal communication with the patient interface assembly. In other embodiments, such communication or power distribution may be performed wirelessly.
[0059] In another embodiment shown in FIG. 9, the control system assembly 200 may include, in operative combination, a primary flow control actuator 222 and a backstop 223 for controlling the flow rate of bodily fluid, a secondary flow shutoff actuator 230 for automatically shutting off the drainage flow in the event of a loss of power or system failure, and a bodily fluid flow sensor 228 for detecting the drainage flow rate.
[0060] In certain embodiments, the bodily fluid flow sensor 228 may be an optical sensor for detecting falling droplets (such as droplets falling through a drip chamber, cuvette, or similar enclosure), a mass flow sensor, an ultrasonic flow sensor, or any other similar sensor capable of detecting the flow of a subject's bodily fluid with clinically acceptable precision and accuracy.
[0061] In certain embodiments, the secondary flow shutoff actuator 230 may be a DC motor with an encoder and a lead screw, a stepper motor with a lead screw, a servo motor, a solenoid, a linear actuator, an electromagnetic latch, or any other similar actuator or latch mechanism that can actuate quickly enough to shut off flow in the event of a loss of power or system failure.
[0062] In certain embodiments, the primary flow control actuator 222 may be a DC motor with an encoder and lead screw, a stepper motor with a lead screw, a servo motor, a solenoid, a linear actuator, or any other similar actuator that provides precise positioning for a near constant flow rate (as in the case of a motor with an encoder, stepper, or servo) or can rapidly actuate between on / off states for intermittent flow (as in the case of a solenoid).
[0063] 10-13 are diagrams illustrating embodiments of the disclosed systems including a customizable sensing assembly, in which detection of one or more analytes is achieved through the use of interchangeable subassemblies that create a sensing platform.
[0064] As shown in FIG. 10, the replaceable analyte detection subassembly 300 may be connected in-line between the cartridge subassembly 101 and the bodily fluid collection reservoir 102 by fluid tight fittings 144 and 301. The replaceable analyte detection subassembly may include an indicator strip 302 coated or impregnated with a reagent formulated for the analyte of interest. In such an embodiment, the indicator strip may remain a starting color (e.g., white) until the analyte of interest reacts with the reagent, which causes the indicator strip to change color (e.g., blue, red, etc.) without changing the color of the liquid in the bodily fluid collection reservoir 102. In a related embodiment, the indicator strip 302 may include a solid plate enzyme-linked immunosorbent assay (ELISA) for detecting proteins using an antibody response.
[0065] 11, the replaceable analyte detection subassembly 300 may include a lab-on-a-chip sensor or other electrical or electrochemical sensor mounted on a PCB or PCBA, is powered by the control system assembly 200 via an electrical cable 310, and communicates results to the control system assembly 200. Alternatively, the replaceable analyte detection subassembly may communicate with the control system assembly or an external display or database via wireless (Wi-Fi, Bluetooth, etc.) signal(s).
[0066] FIG. 12A is a diagram illustrating an embodiment of the disclosed system in which the drainage reservoir is enclosed within the system.
[0067] 12A, the cartridge subassembly 101 may include a drainage reservoir enclosure feature 320 for a drainage reservoir (such as a drainage bag) that slides into a corresponding enclosure feature 250 inside the control system assembly 200. The drainage reservoir enclosure feature 320 may include a removable portion (not shown) for accessing and / or replacing the drainage reservoir. In other embodiments, the drainage reservoir enclosure feature 250 may be an open frame structure that holds but does not completely enclose the drainage reservoir 320 or bodily fluid collection reservoir 102, such that the drainage reservoir and its connection(s) are easily visible and / or accessible to the user.
[0068] FIG. 12B is a diagram illustrating an alternative embodiment of the disclosed customizable sensing assembly including a microfluidic assay interface. As shown in FIG. 12B, the cartridge subassembly 101 can include an assay interface assembly 321 that includes a bodily fluid delivery mechanism and one or more sensing assemblies. The control system assembly 200 can also include access to compatible third-party microfluidic chambers and lateral flow assays, direct or indirect ELISA assays, or other biosensors that are separately inserted. FIG. 13 is a diagram illustrating one such embodiment.
[0069] As shown in FIG. 13, the flow diverter 401 can be disposed on the compliant tube 141 such that the compliant tube 141 is bisected into a lower portion (141a) and an upper portion (141b). The lower portion 141a of the compliant tube can be interfaced with a primary flow control actuator 222 (described elsewhere herein) disposed on the control system assembly to variably pinch or release the compliant tube 141a to inhibit or permit drainage of the subject's bodily fluid. The upper portion 141b of the compliant tube can be interfaced with a secondary flow shutoff actuator 230. The flow diverter 401 can divert flow from the fluid drainage branch 402 to the fluid sampling branch 403. A fluid sample tube 404 (such as a microbore tube, peristaltic pump tube, etc.) can be fluidly connected at one end to the fluid sampling branch 403 of the flow diverter 401 and at the opposite end to a fluid sample distribution assembly 420.
[0070] The fluid sample dispensing assembly 420 may include a frame 421, a guide rod 422, a lead screw 423, and a dispensing nozzle 424. The lead screw 423 may be interfaced with a lead screw actuator 425 (such as a motor) disposed in a control system assembly such that rotational motion of the lead screw 423 is translated into translational motion of the dispensing nozzle 424 by any suitable technique.
[0071] The fluid sample tube 404 can further be positioned between the rollers 431 and the occlusion bed 432 of the peristaltic pump 430, and a known amount of sample(s) can be extracted from the subject's bodily fluid and dispensed into the microfluidic assay 440 by any suitable technique.
[0072] The microfluidic assay 440 may include one or more wells 441 for receiving a fresh bodily fluid sample for analysis and one or more wells 442 for receiving stagnant fluid remaining in the fluid sample tube 404 from a previous sampling event.
[0073] The disclosed system may include several modes of operation depending on the type of therapy delivered and / or sensing modality used. A simplified operational diagram of an exemplary embodiment of the disclosed system is shown in FIG.
[0074] The disclosed system can be configured to provide controlled therapeutic drainage of bodily fluids according to user-defined pressure set points while monitoring user-defined alarm thresholds for parameters such as pressure and flow rate. As shown in FIG. 14, the system can be further configured to monitor the output of one or more sensors to detect one or more analytes, physiological parameters, or motion, and issue alarm(s) or notification(s) to a user when such analytes, contaminants, or toxins are detected. The system can be further configured to utilize detection or concentration of analytes, contaminants, or toxins to provide controlled therapeutic drainage or recirculation of bodily fluids according to machine learning algorithm(s) or user-defined targets. For example, in the case of subdural or subarachnoid hemorrhage, the disclosed system can measure the blood concentration of the CSF continuously or at defined intervals and drain the CSF whenever the concentration exceeds an acceptable low level. Detection of blood concentration can be measured by an analyte sensor or by a physiological sensor that optically evaluates the color of the CSF or uses light sensing at various wavelengths to identify the composition of the bodily fluids.
[0075] The system operating mode(s) can be implemented using a combination of hardware (microcontroller, microprocessor, FPGA, SOM, etc.) and software / firmware.
[0076] The wearable motion sensing assembly of the disclosed system may be located within the wearable pressure sensor assembly 104 or may be a separate wearable assembly.
[0077] In certain embodiments, the system may include one or more wearable motion sensing assemblies configured to track the movement of one or more body parts. As shown in FIG. 15, the wearable motion sensing assemblies may be configured to be attached to the patient's wrist (503), ankle (504), torso / spine (502), head (501), foot (505), or any other suitable location useful for tracking the patient's movement in detail for gait analysis or other related diagnostic purposes. The motion tracking assembly may be attached to the patient by any suitable means known in the art (adhesive patch, hook-and-loop fastener, elastic band, suture, etc.), may be configured to communicate with the control system assembly via any suitable wired (I2C, UART, etc.) or wireless (Bluetooth, Wi-Fi, infrared, etc.) connection protocol known in the art, may be powered by any suitable means known in the art (battery, wired DC power supply, etc.), and may be durable or disposable. The motion tracking assembly may include one or more motion sensing devices (accelerometer(s), gyroscope(s), etc.). These assemblies can also be used in combination to create 2D, 3D, or 4D models of motion. For example, using data from the wearable assemblies 104, 501, 502, 503, 504, and 505, the control system or remote computer and user interface can calculate walking gait (e.g., stride length, stride symmetry, shuffling, etc.) and / or analyze changes in gait over time and communicate them to the user. In further embodiments, the disclosed system can combine motion data with pressure and drainage data to assess the likelihood of normal pressure hydrocephalus (NPH) and the likelihood of successful treatment with an implantable shunt. The disclosed system can accomplish this by assessing gait at the start of drainage and at the end of 48 or 72 hours of drainage, as is currently done, and can improve upon this technology by automating the assessment and quantifying the changes to significantly reduce inter-rater variability.In further embodiments, the control assembly 200 of the disclosed system can continually evaluate data generated by the wearable motion sensor assembly in combination with fluid volume data to detect changes in gait characteristics indicative of a positive diagnosis of NPH at the earliest possible date. Similarly, the disclosed system can simultaneously utilize the above data from the motion sensor and volume drainage, as well as detection of analytes to screen for Parkinson's disease, Alzheimer's disease, or other differential diagnoses in which dementia and gait abnormalities are common symptoms.
[0078] In certain embodiments, the system may employ artificial intelligence (AI) or machine learning (ML) algorithm(s), neural network(s), or similar techniques for geospatial calculations, data analysis, diagnosis determination, calculation of diagnostic probabilities, differential diagnosis, and the like.
[0079] As shown in FIG. 16, a single body fluid can be accessed from multiple anatomical locations. A ventricular catheter 107a accesses and drains CSF in the ventricles via 103a, while a lumbar catheter 107b accesses and drains CSF in the spinal cavity surrounding the spinal cord via 103b. This can be useful to compare relative pressures or fluid properties to characterize the presence or absence of circulation. It can also be used in conjunction with a wearable motion sensor assembly to characterize changes in pressure or other fluid properties as the patient's position or movement changes. For example, the disclosed system could detect changes in lumbar and ventricular pressure from supine to sitting to standing and use analytical modeling or machine learning techniques to approximate the lumbar pressure in the supine position for an upright patient. Similarly, the disclosed system can detect the presence of a hole or tear in the dura that would cause CSF to leak by calculating the expected and actual CSF pressures measured in the lumbar and ventricular regions. The disclosed system can also be configured to monitor cancerous protein levels in the same bodily fluid in different regions of the body to narrow down the location of possible source regions. Wearable pressure sensor assemblies 104a and 104b can also be placed in the thoracic and lumbar regions to monitor blood concentration of CSF in the thoracic region compared to the concentration of CSF draining to the lumbar region to enable determination of whether adequate blood removal is occurring as intended.
[0080] 17A and 17B are schematic representations of a wearable pressure sensor assembly 104 according to certain embodiments of the present disclosure, in which a directional sensor (A) and multiple pressure sensors (P1 and P2) are mounted on a rigid or semi-rigid member (B) at fixed intervals (d). FIG. 17A shows the wearable pressure sensor assembly 104 arranged horizontally with respect to the gravity vector (g). FIG. 17B shows the wearable pressure sensor assembly 104 arranged vertically with respect to the gravity vector (g).
[0081] In a particular aspect of this embodiment, the directional sensor detects the orientation of the wearable pressure sensor assembly 104, thereby facilitating calculation of the expected pressure differential ΔP according to the following equation: ΔP prediction=ρ(Δh) where ρ is the density of the fluid (e.g., density of CSF, saline, blood, urine, etc.) and Δh is the height difference between pressure sensors P2 and P1 relative to the gravity vector.
[0082] As shown in FIG. 17A, when the wearable pressure sensor assembly 104 is oriented horizontally with respect to the gravity vector (g), the pressure measurements of the multiple pressure sensors (P1 and P2) will be substantially equivalent because the height difference (Δh) between the two pressure sensors (P1 and P2) is zero (i.e., Δh=0, and therefore ΔPexpected=0).
[0083] As shown in FIG. 17B, when the wearable pressure sensor assembly 104 is oriented perpendicular to the gravity vector (g), the height difference (Δh) between the two pressure sensors is also maximized, and therefore the pressure difference between the multiple pressure sensors (P1 and P2) is also maximized (i.e., Δh=d, therefore ΔPexpected=ρd).
[0084] If the orientation of any of the wearable sensor assemblies is other than horizontal or vertical, the height difference between the pressure sensors (P1 and P2) varies between 0 and d based on the vertical component of the orientation with respect to the gravity vector (g). The corresponding expected pressure difference ranges from ΔPexpected = 0 to ΔPexpected = ρd.
[0085] In certain embodiments of the control system algorithm, one or both pressure sensors are used to determine the actual measured fluid pressure, while any substantial deviation between ΔP predicted (as described above) and ΔP actual (obtained directly from the pressure sensor readings) can be used by the system to detect pressure sensor faults (electrical faults, drift in sensor accuracy, biofouling, etc.).
[0086] It will be apparent to one of ordinary skill in the art that the present disclosure is applicable to measuring gauge or absolute pressure, either of which can be accomplished by the type of sensors used for P1 and P2, or by including a separate atmospheric pressure sensor(s) outside the fluid path (such as in the control system assembly) for the calculation of gauge pressure.
[0087] The disclosed approach provides two layers of redundancy. First, because each pressure sensor of the wearable pressure sensor assembly 104 is positioned near an anatomical marker of the fluid of interest, the second pressure sensor provides a direct "backup" that allows the system to continue operating even if it is determined that either sensor is no longer functioning properly. Second, the system can detect slight drifts in the accuracy of the wearable sensor assembly and take appropriate action (such as notifying the user) before such errors become clinically significant.
[0088] The disclosed approach differs from existing two-sensor systems in which one sensor measures pressure in a fluid line of interest and a second sensor measures pressure in a separate reference line, with both pressure sensors located elsewhere than at an associated anatomical marker (e.g., on a pole-mounted console or a waist-worn wearable). In such systems, the true pressure of the fluid of interest (e.g., true ICP) is calculated as the difference between the pressure in the drain line and the pressure in the separate reference line.
[0089] The two sensor placements described in the prior art provide no redundancy and limited opportunity for error checking, leaving patients susceptible to sensor drift and similar disturbances. Co-locating two pressure and directional sensors in substantial proximity to relevant anatomical markers, as described in this disclosure, enables unprecedented levels of measurement accuracy and clinical safety.
[0090] It will be appreciated that the wearable pressure sensor assembly 104 must be small enough and lightweight to facilitate attachment to specific anatomical markers (such as the EAM on the head, or L4-L5 in the lumbar region of the lower back) to achieve practical use. Thus, the use of small enough pressure sensors suitable for prolonged contact with bodily fluids and also with sufficient accuracy and precision to enable clinical utility is important in achieving the disclosed embodiments. Additionally, the spacing between sensors must be small enough to facilitate a suitable overall footprint of the assembly, which places further constraints on the accuracy of the pressure sensors to enable useful drift detection, as described elsewhere herein. For example, spacing on the order of a few centimeters is only useful if the pressure sensor can resolve pressure differences on the order of a few millimeters of water (mmH2O). Until recently, such pressure sensors were unknown in the industry, making such embodiments impractical. However, recent technological developments now allow for spacings (d) in the range of 1-2 cm using small (2-3 mm wide) pressure sensors with an accuracy of around ±1 mmH2O, resulting in an overall footprint of 2-5 cm2 with the characteristics described herein. 2 A range of practical implementations of wearable pressure sensor assemblies are now possible.
[0091] U.S. Provisional Patent Application Nos. 63 / 275,232, filed November 3, 2021, and 63 / 315,910, filed March 2, 2022, from which this application claims priority, are incorporated herein by reference in their entirety. The various embodiments described above can be combined to provide further embodiments. These and other changes can be made to the embodiments in light of the above detailed description. In general, the terms used in the following claims should not be construed as limiting the claims to the specific embodiments disclosed in the specification and claims, but rather as including all possible embodiments along with the full scope of equivalents to which such claims are entitled.
Claims
1. 1. A body fluid management system comprising: a control system assembly for real-time monitoring of the pressure of a body fluid; a patient interface assembly including at least one wearable pressure sensor assembly; and at least one sensor assembly configured to detect at least one parameter of the bodily fluid.
2. The system of claim 1 , wherein the control system assembly includes an integrated control of the drainage of the bodily fluids.
3. The system of claim 1 , wherein the wearable pressure sensor assembly is configured to be attached near an anatomical marker of a patient.
4. The system of claim 1 , wherein the wearable pressure sensor assembly comprises at least one pressure sensor in direct fluid communication with the bodily fluid.
5. The system of claim 1 , wherein the control system is configured to monitor changes in pressure of the bodily fluid.
6. The system of claim 1 , wherein the at least one sensor assembly is an analyte sensor assembly in direct fluid communication with the bodily fluid.
7. The system of claim 6 , wherein the control system assembly includes an integrated control of the drainage of the bodily fluids.
8. The system of claim 6 , wherein the analyte sensor is disposed within a sealed fluid path of the bodily fluid.
9. The system of claim 6 , wherein the analyte sensor assembly is configured to detect a salinity of the bodily fluid.
10. The system of claim 6 , wherein the analyte sensor assembly is configured to detect a glucose concentration of the bodily fluid.
11. The system of claim 6 , wherein the analyte sensor assembly is configured to detect a concentration of a protein in the bodily fluid.
12. The system of claim 1 , wherein the at least one sensor assembly is a physiological sensor assembly.
13. The system of claim 12 , wherein the physiological sensor assembly is configured to detect a color of the bodily fluid.
14. The system of claim 12 , wherein the physiological sensor assembly is configured to detect an opacity of the bodily fluid.
15. The system of claim 12 , wherein the physiological sensor assembly is configured to detect particles in the bodily fluid.
16. The system of claim 12 , wherein the physiological sensor assembly is configured to detect an oxygen concentration of the bodily fluid.
17. The system of claim 1 , wherein the control system communicates a quantitative value obtained from the sensor assembly.
18. The system of claim 1 , wherein the control system communicates a qualitative parameter from the sensor assembly.
19. 1. A body fluid management system comprising: a control system assembly for real-time monitoring of the pressure of the body fluid and for coordinated control of the drainage of said body fluid; a patient interface assembly including at least one wearable pressure sensor assembly; and The system includes at least one customizable sensor assembly configured to integrate a replaceable sensor subassembly.
20. The system of claim 19 , wherein the replaceable sensor subassembly is a replaceable analyte detection subassembly.
21. The system of claim 19 , wherein the replaceable sensor subassembly includes a printed circuit board.
22. The system of claim 21 , wherein the replaceable sensor subassembly is in communication with the control system assembly.
23. 1. A body fluid management system comprising: a control system assembly for real-time monitoring of the pressure of the body fluid and for coordinated control of the drainage of said body fluid; a patient interface assembly including at least one wearable pressure sensor assembly; and The system includes at least one wearable motion sensor assembly.
24. 24. The system of claim 23, wherein the patient interface assembly comprises at least one directional sensor configured to detect an orientation of and movement of a body cavity containing the bodily fluid.
25. 24. The system of claim 23, wherein the wearable motion sensor assembly includes at least one motion sensor configured to detect movement of the body.
26. 24. The system of claim 23, wherein the at least one wearable motion sensor assembly includes two wearable motion sensor assemblies, one configured to be worn on each ankle.
27. 24. The system of claim 23, wherein the at least one wearable motion sensor assembly includes two wearable motion sensor assemblies configured to be mounted one on each shoe.
28. 24. The system of claim 23, wherein the at least one wearable motion sensor assembly is configured to be worn in a lumbar region.
29. 24. The system of claim 23, wherein the control system assembly is configured to derive gait from inputs of a patient interface assembly.
30. 30. The system of claim 29, wherein the control system assembly is configured to detect normal pressure hydrocephalus that may be ameliorated by a shunt.
Citation Information
Patent Citations
Wound exudate system accessory
JP2014507961A
Sensing Foley catheter
JP2016531650A
Systems, devices and methods for draining and analyzing bodily fluids
JP2018538116A
Transducer holder
US20050137496A1
Chemical sensor with replaceable sample collection chip
US20120171774A1
